Vanderbilt-Ingram Cancer Center Signs On With Open Biosystems’ Open Access(TM) Program For Breast Cancer Research; Leading Cancer Centers Continue To Recognize The Value Of shRNAmir And cDNA Technology

HUNTSVILLE, Ala.--(BUSINESS WIRE)--Sept. 11, 2006--Open Biosystems, Inc., focused on the commercialization of leading-edge life science research tools for drug discovery, today announced that Vanderbilt-Ingram Cancer Center, a recognized leader in cancer prevention, care and research, has joined its Open Access Program for RNAi and cDNA resources
MORE ON THIS TOPIC